Related Experiment Video
Updated: Jun 15, 2025

08:50
A Nonsequencing Approach for the Rapid Detection of RNA Editing
Published on: April 21, 2022
2.6K
A-to-I RNA editing and hematopoiesis
Zhen Liang1, Carl R Walkley1, Jacki E Heraud-Farlow1
1St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia; Department of Medicine, Eastern Hill Precinct, Melbourne Medical School, University of Melbourne, Fitzroy, Victoria, Australia.
Experimental Hematology
|August 26, 2024
Summary
Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by ADAR enzymes, is crucial for development and homeostasis. This review highlights ADAR1
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Adenosine-to-inosine (A-to-I) RNA editing is a critical post-transcriptional modification.
- This process is primarily mediated by the adenosine deaminase acting on RNA (ADAR) enzyme family.
- ADAR1 and ADAR2 are key players in innate immunity and neurological development, respectively.
Purpose of the Study:
- To review the role of A-to-I RNA editing and ADAR enzymes in normal hematopoiesis.
- To specifically focus on the function of ADAR1 in blood cell development.
- To discuss the utility of Adar1 mouse models in studying hematopoiesis and innate immunity.
Main Methods:
- Literature review of studies on A-to-I RNA editing and ADAR enzymes.
- Analysis of data from Adar1 mouse models.
- Examination of the interplay between ADAR1, hematopoiesis, and innate immunity.
Main Results:
- A-to-I RNA editing by ADAR1 is essential for proper hematopoiesis.
- ADAR1 plays a significant role in regulating innate immune pathways.
- Adar1 mouse models provide valuable insights into these processes.
Conclusions:
- ADAR1 is a key regulator of normal hematopoiesis.
- Understanding ADAR1's function is crucial for both developmental biology and immunology.
- Further research using Adar1 models will elucidate complex biological mechanisms.
Related Concept Videos
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
pre-mRNA Processing
52.8K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
52.8K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K

